23 Nov 2022
A template of protocol for use of Macimorelin for the diagnosis of adult GHD and the associated patient information leaflet are now available on the Society for Endocrinology (SfE) resource page which can be accessed by all SfE members.
An expert panel chaired by Márta Korbonits and Sherwin Criseno developed a protocol and patient info leaflet for the use of the new dynamic stimulation test macimorelin in the diagnosis of adult GHD. The protocol and PIL can be used as a template and adapt according to each organisation’s requirement and process. Copy of the protocol and PIL can be found on SfE Resource hub here.
Endocrine-disrupting chemical levels found at alarming levels in Australia
11 Apr 2024
Risk of depression during menopause transition not universal
11 Apr 2024
Patients with long Covid continue to show inflammatory proteins in blood
11 Apr 2024
People with obesity and high weight linked to feeling increased pain intensity
11 Apr 2024